Yudai Shinohara
Yudai Shinohara publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research and Colorectal Cancer Treatments and Studies.
- World rank
- #3,964,255 of 7,710,434 ranked researchers
- Rank in Japan
- #105,396 of 383,136
- Works
- 57
- Citations
- 291
- Citations per work
- 5.1
What does Yudai Shinohara research?
Yudai Shinohara's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (4%), Engineering (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3460.1%
- Medicine3460.1%
- Everything else1933.0%
- Life Sciences23.8%
- Physical Sciences23.1%
- Engineering23.1%
- 1Oncology31% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Surgery10% of their works
- 4Molecular Biology4% of their works
- 5Epidemiology4% of their works
- 6Control and Systems Engineering3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Neuroendocrine Tumor Research Advances
- Inflammatory Biomarkers in Disease Prognosis
Which keywords describe Yudai Shinohara's research?
The keywords of their largest research topics: Chemotherapy, Tumor Microenvironment, Survival Analysis, Immunotherapy, Endoscopic Resection, Gastric Cancer, Prognostic Factors and Cetuximab.
- Pancreatic Neuroendocrine Tumors
- Inflammation
- Small-Cell Lung Cancer
- PD-1 and PD-L1
- Cholangiocarcinoma
- Metastasis
- Pancreatic Cancer
- Cetuximab
- Gastric Cancer
- Immunotherapy
- Tumor Microenvironment
- Chemotherapy
- Survival Analysis
- Endoscopic Resection
- Prognostic Factors
- KRAS Mutations
- Surgical Complications
- Biliary Tract Cancer
- Immune Checkpoint Blockade
- Genomic Profiles
- Cancer
- Neuroendocrine Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Chemotherapy384 topics
- Tumor Microenvironment203 topics
- Survival Analysis172 topics
- Immunotherapy152 topics
- Endoscopic Resection131 topic
- Gastric Cancer131 topic
- Prognostic Factors132 topics
- Cetuximab101 topic
- KRAS Mutations101 topic
- Pancreatic Cancer101 topic
- Surgical Complications101 topic
- Metastasis92 topics
- Biliary Tract Cancer81 topic
- Cholangiocarcinoma81 topic
- Immune Checkpoint Blockade61 topic
- PD-1 and PD-L161 topic
- Genomic Profiles51 topic
- Small-Cell Lung Cancer51 topic
- Cancer41 topic
- Inflammation41 topic
- Neuroendocrine Tumors41 topic
- Pancreatic Neuroendocrine Tumors41 topic
Where does Yudai Shinohara work?
Yudai Shinohara's main affiliation in the publication record is Kyushu Hospital, Japan.
How many publications and citations does Yudai Shinohara have?
OpenAlex counts 57 works and 291 citations for Yudai Shinohara, an h-index of 11, ranking #3,964,255 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yudai Shinohara. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.